Pill with imprint LI is White, Oval and has been identified as Levocetirizine Dihydrochloride 5 mg. It is supplied by Micro Labs Limited. Levocetirizine is used in the treatment of Urticaria; Allergic Rhinitis; Allergies; Food Allergies and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy.

This white elliptical / oval pill with imprint LI on it has been identified as: Levocetirizine 5 mg. This medicine is known as levocetirizine. It is available as a prescription and/or OTC medicine and is commonly used for Allergic Rhinitis, Allergies, Urticaria, Food Allergies.

Use the pill finder to identify medications by visual appearance or medicine name. Pill Imprint Tip: Enter the imprint only first . Refine by color or shape if too many results display.

Pill Identifier results for "1LI White and Capsule/Oblong". Search by imprint, shape, color or drug name.

Discover a wide range of medications that begin with the letter LI on WebMD. Get comprehensive drug information, including uses, side effects, and more.

This white round pill with imprint LI 40 on it has been identified as: Lisinopril 40 mg. This medicine is known as lisinopril. It is available as a prescription only medicine and is commonly used for Alport Syndrome, Coronary Artery Disease, Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure, Migraine Prevention ...

Learn about changes that make it easier for people to get Lilly insulin for $35 or less a month. When health is lost, the only thing you want is to get better. It’s why we’re working to make …

LI DAN PAI SHI or LIDAN PAISHI PIAN - Benefit Gallbladder Expel Stone Tablet: for dissolving and discharging gallstones. Useful for acute and chronic hepatitis.

Pill Identifier results for "li Capsule/Oblong". Search by imprint, shape, color or drug name.

2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen yet in...